跳至主要内容
临床试验/NCT00992888
NCT00992888已完成不适用

Inflammation, Immune Activation and Portal Hypertension in Alcoholic Hepatitis. A Pato-etiological Study With Focus on the Endotoxin Pathway.

University of Aarhus2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2009年8月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
60
试验地点
2
主要终点
Serum endotoxin levels

研究概览

简要总结

The purpose of this study is to investigate the role of endotoxins and the endotoxin mediated immune activation pathway in patients with alcoholic hepatitis. Also, to determine the effect of Liver assist (liver dialyses) intervention on these parameters in patients with severe alcoholic hepatitis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 69 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with alcoholic hepatitis based on the following criteria
  • Alcohol intake for 6 consecutive months above 40g /day, at admission or 3 months earlier.
  • Serum bilirubin level above 80 mmol/l
  • exclusion of other types of liver disease.
  • Liver biopsy when diagnosis is unclear.

排除标准

  • Heart failure
  • Pregnancy
  • non fluent danish speakers

结局指标

主要结局

Serum endotoxin levels

时间窗: one year

次要结局

  • Endotoxin activation pathway proteins(1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Thomas Damgaard Sandahl

Dr

University of Aarhus

研究点 (2)

Loading locations...

相似试验

Inflammation, Immune Activation and Portal... | 临床试验